Treatment of cardiac risk factors among patients with schizophrenia and diabetes

Psychiatric Services

Volumn 57, Issue 8, 2006, Pages 1145-1152

  Weiss, Anthony P ^a   Henderson, David C ^a   Weilburg, Jeffrey B ^a   Goff, Donald C ^a   Meigs, James B ^b   Cagliero, Enrico ^b   Grant, Richard W ^b  

^a Department of Psychiatry ^*

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; COLESTIPOL; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; GEMFIBROZIL; NEUROLEPTIC AGENT; NICOTINIC ACID; STATIN; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LIFE EXPECTANCY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; SCHIZOPHRENIA; WELLBEING;

EID: 33746967632     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2006.57.8.1145     Document Type: Article

References (32)

1. Newman SC, Bland RC: Mortality in a cohort of patients with schizophrenia: a record linkage study. Canadian Journal of Psychiatry 36:239-245, 1991
2. Harris EC, Barraclough B: Excess mortality of mental disorder. British Journal of Psychiatry 173:11-53, 1998
3. Brown S: Excess mortality of schizophrenia: a meta-analysis. British Journal of Psychiatry 171:502-508, 1997
4. Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177:212-217, 2000
5. Goff DC, Cather C, Evins AE, et al: Medical morbidity arid mortality in schizophrenia: guidelines for psychiatrists. Journal of Clinical Psychiatry 66:183-194, 2005
6. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et al: Consensus development conference on antipsychotic drags and obesity and diabetes. Diabetes Care 27:596-601, 2004
7. Wilson P, D'Agostino R, Levy D, et al: Prediction of coronary heart disease risk using risk factor categories. Circulation 97:1837-1847, 1998
8. Gaede P, Pederson O: Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes 53(suppl): S39-S47, 2004
9. Marder SR, Essock SM, Miller AL, et al: Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 161:1334-1349, 2004
10. Casey DE, Haupt DW, Newcomer JW, et al: Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. Journal of Clinical Psychiatry 65(suppl):S4-S18, 2004
11. Newcomer JW, Nasrallah HA, Loebel AD: The Atypical Antipsychotic Therapy and Metabolic Issues National Survey. Journal of Clinical Psychopharmacology 24(suppl 1):S1-S6, 2004
12. Druss BG, Rosenheck KA, Desai MM, et al: Quality of preventive medical care for patients with mental disorders. Medical Care 40:129-136, 2002
13. Druss BC, Bradford DW, Rosenheck RA, et al: Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 283:506-511, 2000
14. Levinson Miller C, Druss BG, Dombrowski EA, et al: Barriers to primary medical care among patients at a community mental health center. Psychiatric Services 54: 1158-1160, 2003
15. Jones LE, Clarke W, Carney CP: Receipt of diabetes services by insured adults with and without claims for mental disorders. Medical Care 42:1167-1175, 2004
16. Desai MM, Rosenheck RA, Druss BG, et al: Mental disorders and quality of diabetes care in the Veterans Health Administration. American Journal of Psychiatry 159:1584-1590, 2002
17. Frayne SM, Halanych JH, Miller DR, et al: Disparities in diabetes care: impact of mental illness. Archives of Internal Medicine 165:2631-2638, 2005
18. Dolder CR, Lacro JP, Jeste DV: Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Psychosomatic Medicine 65:156-162, 2003
19. Dickerson KB, Goldberg RW, Brown CH, et al: Diabetes knowledge among persons with serious mental illness and type 2 diabetes. Psychosomatics 46:418-424, 2005
20. Ciechanowski PS, Katon WJ, Russo JE, et al: The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. General Hospital Psychiatry 25:246-252, 2003
21. Wexler DJ, Grant RW, Meigs JB, et al: Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28:514-520, 2005
22. Nazareth I, King M, Haines A, et al: Accuracy of diagnosis of psychosis on general practice computer system. British Medical Journal 307:32-34, 1993
23. Gaede P, Vedel P, Parving HH, et al: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617-622, 1999
24. Gaede P, Vedel P, Larsen N, et al: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New England Journal of Medicine 348:383-393, 2003
25. State of Health Care Quality Report: Comprehensive Diabetes Care, 2003. Washington, DC, National Committee for Quality Assurance
26. Grundy SM, Benjamin IJ, Burke GL, et al: Diabetes and cardiovascular disease. Circulation 100:1134-1146, 1999
27. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 24(suppl):S33-S43, 2001
28. Meyer JM, Koro CE: The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophrenia Research 70:1-17, 2004
29. Karter AJ, Ackerson LM, Darbinian JA, et al: Self-monitoring of blood glucose levels arid glycemic control: the Northern California Kaiser Permanente diabetes registry. American Journal of Medicine 111:1-9, 2001
30. Rubin RR: Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. American Journal of Medicine 118(suppl):27S-34S, 2005
31. Dixon LB, Kreyenbuhl JA, Dickerson FB, et al: A comparison of type 2 diabetes outcome among persons with and without severe mental illnesses. Psychiatric Services 55:892-900, 2004
32. Desai MM, Rosenheck RA, Druss BG, et al: Receipt of nutrition and exercise counseling among medical outpatients with psychiatric and substance use disorders. Journal of General Internal Medicine 17:556-560, 2002